AbCellera Biologics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -21.6% | -21.6% | — |
| FY2020 | 14.3% | 14.3% | 11.8% |
| FY2021 | 15.0% | 15.0% | 11.6% |
| FY2022 | 12.9% | 12.9% | 10.3% |
| FY2023 | -12.7% | -12.7% | -9.8% |
| FY2024 | -15.4% | -15.4% | -12.0% |
| FY2025 | -15.1% | -15.1% | -10.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -21.6% | -21.6% | — |
| FY2020 | 14.3% | 14.3% | 11.8% |
| FY2021 | 15.0% | 15.0% | 11.6% |
| FY2022 | 12.9% | 12.9% | 10.3% |
| FY2023 | -12.7% | -12.7% | -9.8% |
| FY2024 | -15.4% | -15.4% | -12.0% |
| FY2025 | -15.1% | -15.1% | -10.8% |